33
/
AIzaSyAYiBZKx7MnpbEhh9jyipgxe19OcubqV5w
October 1, 2025
Create a timeline
Public Timelines
For education
For educational institutions
For teachers
For students
Cabinet
For educational institutions
For teachers
For students
Open cabinet
FAQ
Get premium
Close
Create a timeline
Public timelines
Library
FAQ
About & Feedback
Terms
Privacy
Library
FAQ
Support 24/7
Cabinet
Get premium
Donate
The service accepts bank transfer (ACH, Wire) or cards (Visa, MasterCard, etc). Processed by Stripe.
Secured with SSL
Edit
Download
Export
Duplicate
Premium
Embed
Share
asdfg
Category:
Other
Updated:
16 Oct 2017
0
0
404
Contributors
Created by
Daniel Rossi
Attachments
Comments
Events
Founded as Genetix Pharmaceuticals
Jesse Gelsinger Dies, Interest Lost in Gene Therapy
Series A Financing, $20 million raised
Phase I/II Beta Thallassemia trial launched
Genetix Launches ADL Program
Series B, $35 million raised, new CEO from Third Rock Ventures
Series C, $35 million
Series D, $60 million
Initial Public Offering, $116 million
Cash assets expected to run out
Phase 3 End Date, Beta Thalassemia
Phase 2/3 end date, ALD
About & Feedback
Terms
Privacy
Library
FAQ
Support 24/7
Cabinet
Get premium
Donate
The service accepts bank transfer (ACH, Wire) or cards (Visa, MasterCard, etc). Processed by Stripe.
Secured with SSL
Comments